On November 7, 2025, scientists investigating the mechanisms and clinical applications of GMI, an immunomodulatory protein derived from Ganoderma microsporum, gathered with medical professionals and health specialists interested in GMI at the National Taiwan University Hospital International Convention Center for an interdisciplinary academic exchange.  This was the first scholarly symposium devoted exclusively to a single Ganoderma constituent since the world's first Ganoderma symposium in ...